These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 9181602)
1. Pharmacokinetics, toxicity, side effects, receptor affinities and in vitro radiosensitizing effects of the novel metoclopramide formulations, sensamide and neu-sensamide. Pero RW; Olsson A; Simanaitis M; Amiri A; Andersen I Pharmacol Toxicol; 1997 May; 80(5):231-9. PubMed ID: 9181602 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and central nervous system toxicity of declopramide (3-chloroprocainamide) in rats and mice. Hua J; Pero RW; Kane R Anticancer Drugs; 1999 Jan; 10(1):79-88. PubMed ID: 10194550 [TBL] [Abstract][Full Text] [Related]
3. Comparative central nervous system effects and pharmacokinetics of neu-metoclopramide and metoclopramide in healthy volunteers. Rotmensch HH; Mould GP; Sutton JA; Kilminster S; Moller C; Pero RW J Clin Pharmacol; 1997 Mar; 37(3):222-8. PubMed ID: 9089424 [TBL] [Abstract][Full Text] [Related]
4. Differential interactions of traditional and novel antiemetics with dopamine D2 and 5-hydroxytryptamine3 receptors. Hamik A; Peroutka SJ Cancer Chemother Pharmacol; 1989; 24(5):307-10. PubMed ID: 2527092 [TBL] [Abstract][Full Text] [Related]
5. Neutral metoclopramide sensitizes cytotoxicity induced by ionizing radiation in SCID mice xenografted with a human brain astrocytoma. Hua J; Olsson AR; Pero RW Int J Cancer; 1997 Dec; 73(6):871-4. PubMed ID: 9399668 [TBL] [Abstract][Full Text] [Related]
6. A novel series of N-(hexahydro-1,4-diazepin-6-yl) and N-(hexahydroazepin- 3-yl)benzamides with high affinity for 5-HT3 and dopamine D2 receptors. Hirokawa Y; Morie T; Yamazaki H; Yoshida N; Kato S Bioorg Med Chem Lett; 1998 Mar; 8(6):619-24. PubMed ID: 9871571 [TBL] [Abstract][Full Text] [Related]
7. Acidic and neutralized metoclopramide formulations sensitize ionizing radiation induced cytotoxicity in a human lung adenocarcinoma xenografted to scid mice. Hua J; Olsson A; Sheng Y; Pero RW Anticancer Drugs; 1995 Jun; 6(3):451-5. PubMed ID: 7670144 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationships of 4-amino-5-chloro-N-(1,4-dialkylhexahydro-1,4-diazepin-6-yl)-2-methoxybenzamide derivatives, novel and potent serotonin 5-HT3 and dopamine D2 receptors dual antagonist. Hirokawa Y; Harada H; Yoshikawa T; Yoshida N; Kato S Chem Pharm Bull (Tokyo); 2002 Jul; 50(7):941-59. PubMed ID: 12130853 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity. Hirokawa Y; Fujiwara I; Suzuki K; Harada H; Yoshikawa T; Yoshida N; Kato S J Med Chem; 2003 Feb; 46(5):702-15. PubMed ID: 12593651 [TBL] [Abstract][Full Text] [Related]
11. The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D2, D3 and 5-HT3 receptors antagonist. Yoshikawa T; Yoshida N; Oka M Br J Pharmacol; 2001 May; 133(2):253-60. PubMed ID: 11350861 [TBL] [Abstract][Full Text] [Related]
12. Emesis and defecations induced by the 5-hydroxytryptamine (5-HT3) receptor antagonist zacopride in the ferret. King GL J Pharmacol Exp Ther; 1990 Jun; 253(3):1034-41. PubMed ID: 2162943 [TBL] [Abstract][Full Text] [Related]
13. Comparison of oral 5-HT3-receptor antagonists and low-dose oral metoclopramide plus i.m. dexamethasone for the prevention of delayed emesis in head and neck cancer patients receiving high-dose cisplatin. Mantovani G; Macciò A; Curreli L; Lampis B; Ghiani M; Bianchi A; Contu P Oncol Rep; 1998; 5(1):273-80. PubMed ID: 9458381 [TBL] [Abstract][Full Text] [Related]
14. Non-additivity of D2 receptor proliferation induced by dopamine denervation and chronic selective antagonist administration: evidence from quantitative autoradiography indicates a single mechanism of action. LaHoste GJ; Marshall JF Brain Res; 1989 Nov; 502(2):223-32. PubMed ID: 2531015 [TBL] [Abstract][Full Text] [Related]
15. Impaired Clearance From the Brain Increases the Brain Exposure to Metoclopramide in Elderly Subjects. Bauer M; Bamminger K; Pichler V; Weber M; Binder S; Maier-Salamon A; Tahir A; Jäger W; Haslacher H; Tournier N; Hacker M; Zeitlinger M; Langer O Clin Pharmacol Ther; 2021 Mar; 109(3):754-761. PubMed ID: 32966590 [TBL] [Abstract][Full Text] [Related]
17. Investigation of developmental toxicity and teratogenicity of antiemetics on rat embryos cultured in vitro. Fazliogullari Z; Karabulut AK; Uysal II; Unver Dogan N; Acar H Anat Histol Embryol; 2013 Aug; 42(4):239-46. PubMed ID: 23002952 [TBL] [Abstract][Full Text] [Related]
18. Abortifacient effect of metoclopramide in female albino rats. Shrestha JM; Shrestha R; Khanal K Kathmandu Univ Med J (KUMJ); 2013; 11(41):9-13. PubMed ID: 23774405 [TBL] [Abstract][Full Text] [Related]
19. Interactions between metoclopramide and morphine: enhanced antinociception and motor dysfunction in rats. Kamerman PR; Becker N; Fick LG Clin Exp Pharmacol Physiol; 2007; 34(1-2):106-12. PubMed ID: 17201744 [TBL] [Abstract][Full Text] [Related]